Pacific Biosciences of California share are trading lower after Morgan Stanley lowered its price target on the stock from $4 to $2.
Portfolio Pulse from Benzinga Newsdesk
Pacific Biosciences of California shares are trading lower after Morgan Stanley lowered its price target on the stock from $4 to $2.
August 12, 2024 | 5:59 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley has lowered its price target for Pacific Biosciences of California from $4 to $2, causing the stock to trade lower.
The reduction in the price target by a major financial institution like Morgan Stanley is likely to negatively impact investor sentiment and lead to a short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100